Basel, 31 May 2010
Roche Investor Event: ASCO 2010 - Analyst briefing on data presented at ASCO: Sunday, June 6
Analyst briefing on data presented at ASCO: Sunday, June 6
We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (June 4-8, 2010).
We will have a significant presence at the congress with almost 400 scientific abstracts submitted. A summary of the key data presented at ASCO will be provided at the Analyst briefing.
Palmer House Hilton
Meeting room: Adams Ballroom (Meeting room floor no. 6)
17 East Monroe Street
Chicago, IL 60603
In order to assist you, we have prepared an ASCO planner providing an overview of oral and poster abstracts relevant to us, including indication of time and venue of the presentation. This planner can be downloaded from our website via http://www.roche.com/asco-planner-2010.pdf.
Sunday, 6 June, 2010
6.30 pm to 8.00 pm Central Daylight time CDT (Chicago)
followed by a buffet reception
1.30 am to 3.00 am CEST (Switzerland) on Monday, 7 June 2010
0.30 am to 2.00 am BST (London) on Monday, 7 June 2010
Setting the standard of care in oncology
Pascal Soriot, COO Roche Pharmaceuticals
Avastin in ovarian cancer, GOG-0218 study data
Jakob Dupont, M.D., M.A., Associate Group Medical Director Avastin Global ClinicalDevelopment, Genentech
Overview of Avastin development program
Stefan Frings, M.D., Ph.D., Avastin Franchise Director, Roche
MabThera/Rituxan maintenance in previously untreated patients with follicular lymphoma (PRIMA study)
Gilles Salles, M.D., Ph.D., Principal Investigator of PRIMA study Centre Hospitalier Lyon-Sud, France
Overview of Roche/Genentech oncology pipeline
Hal Barron, M.D., Executive Vice President, Global Development and Chief Medical Officer, Roche
Dial in to the conference 10-15 min prior to the scheduled start using the following numbers:
+41 (0) 91 610 56 00 (EU and RoW)
+44 (0) 207 107 06 11 (UK)
+1 (1) 866 291 4166 (USA – toll free)
Alternatively a live audio webcast can be accessed via http://ir.roche.com.
The presentation slides will be available from the IR website at http://ir.roche.com following to the closure of the ASCO meeting.
A replay of the conference call will be available one hour after the conference call, for 48 hours. Access is by dialing:
+41 91 612 43 30 (EU and RoW)
+44 207 108 62 33 (UK)
+1 (1) 866 416 25 58 (USA)
and will be asked to enter the ID 14374 followed by the # sign.